enbucrilate has been researched along with Alzheimer Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, U; Elsinghorst, PW; Grosche, J; Gütschow, M; Härtig, W; Hoffmann, A; Kacza, J; Paulke, BR | 1 |
| Juvonen, RO; Mahadik, KR; Mönkkönen, J; Mulik, RS; Paradkar, AR | 1 |
| Harkany, T; Härtig, W; Kacza, J; Paulke, BR; Seeger, J; Varga, C | 1 |
| Kumar, KP; Paramakrishnan, N; Samanta, MK; Santhi, K; Suresh, B; Wilson, B | 1 |
4 other study(ies) available for enbucrilate and Alzheimer Disease
| Article | Year |
|---|---|
In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles.
Topics: Acridines; Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Cholinesterase Inhibitors; Chromones; Disease Models, Animal; Drug Delivery Systems; Enbucrilate; Fluorescent Dyes; Hippocampus; Humans; Mice; Mice, Transgenic; Nanoparticles; Plaque, Amyloid; Polymethacrylic Acids; Polystyrenes; Presenilin-1; tau Proteins | 2010 |
ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E3; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Curcumin; Enbucrilate; Flow Cytometry; Humans; Models, Theoretical; Nanoparticles; Polymers; Reactive Oxygen Species; X-Ray Diffraction | 2010 |
Electron microscopic analysis of nanoparticles delivering thioflavin-T after intrahippocampal injection in mouse: implications for targeting beta-amyloid in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzothiazoles; Drug Carriers; Drug Delivery Systems; Enbucrilate; Female; Fluorescent Dyes; Hippocampus; Injections; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Nanotechnology; Particle Size; Polymers; Polystyrenes; Thiazoles | 2003 |
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Delivery Systems; Enbucrilate; Male; Nanoparticles; Phenylcarbamates; Polysorbates; Rats; Rats, Wistar; Rivastigmine; Surface-Active Agents; Up-Regulation | 2008 |